Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer’s Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study V. Pérez-GrijalbaJ. RomeroThe AB255 Study Group Original Research 19 October 2018 Pages: 34 - 41
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer’s Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? Donna A. MessnerP. RabinsD. Wuest Original Research 19 October 2018 Pages: 20 - 26
Revisiting the Cholinergic Hypothesis in Alzheimer’s Disease: Emerging Evidence from Translational and Clinical Research Harald HampelM.-M. MesulamCholinergic System Working Group, and for the Alzheimer Precision Medicine Initiative (APMI) Point of View 19 October 2018 Pages: 2 - 15
What We Learn from the CTAD 2018 (Clinical Trials Alzheimer’s Disease) Bruno VellasP. AisenJ. Touchon Editorial 02 October 2018 Pages: 214 - 215
Geographic Clusters of Alzheimer’s Disease Mortality Rates in the USA: 2008-2012 R. W. AminE. M. YackoRodney P. Guttmann Original Research 26 September 2018 Pages: 231 - 235
Preventing Dementia through Community Involvement and Altruistic Behaviors Yohko Maki Letter to the Editor 24 September 2018 Pages: 259 - 260
Clinical Application of APOE in Alzheimer’s Prevention: A Precision Medicine Approach C. L. BerkowitzL. MosconiRichard S. Isaacson Review 14 September 2018 Pages: 245 - 252
Female Sex and Alzheimer’s Risk: The Menopause Connection O. ScheyerA. RahmanLisa Mosconi Original Research 12 September 2018 Pages: 225 - 230
Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study Yodai KobayashiT. KinoshitaJ.-Z. Xiao Short Communication 27 August 2018 Pages: 70 - 75
Pimavanserin: Potential Treatment For Dementia-Related Psychosis Jeffrey CummingsC. BallardS. Stankovic Review Open access 16 August 2018 Pages: 253 - 258
Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer’s Disease: Results from a Longitudinal Study John E. HarrisonD. M. RentzE. Liu Original Research 16 August 2018 Pages: 236 - 244
Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms Clive BallardJ. M. YouakimS. Stankovic Original Research Open access 16 August 2018 Pages: 27 - 33
Assessment of Instrumental Activities of Daily Living in Older Adults with Subjective Cognitive Decline Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) Alexandra S. AtkinsA. KhanR. S. E. Keefe Original Research 05 July 2018 Pages: 216 - 224
An Action Plan to Face the Challenge of Dementia: INTERNATIONAL STATEMENT ON DEMENTIA from IAP for Health H. ChertkowResearch Executive Committee of the Canadian Consortium on Neurodegeneration in AgingInternational IAP committee on Dementia Position Paper Open access 20 June 2018 Pages: 207 - 212
WHO Guidelines on Community-Level Interventions to Manage Declines in Intrinsic Capacity: The Road to Prevention Cognitive Decline in Older Age? B. VellasD. ScraseL. T. Middleton Editorial 13 June 2018 Pages: 165 - 167
Turning Point towards Blood Biomarker-Guided Targeted Therapy for Precision Medicine in Alzheimer’s Disease Harald HampelA. VergalloAlzheimer Precision Medicine Initiative (APMI) Editorial 13 June 2018 Pages: 160 - 164
Plasma Biomarker for Alzheimer’s Disease: Are We Ready Now for Clinical Practice and Drug Trials? A. Nakamura Editorial 12 June 2018 Pages: 158 - 159
Analysis of the Relationship of Cognitive Impairment and Functional Impairment in Mild Alzheimer’s Disease in EXPEDITION 3 Hong Liu-SeifertE. SiemersP. Aisen Original Research 29 May 2018 Pages: 184 - 187
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force P. S. AisenE. SiemersEU/US/CTAD Task Force members CTAD Task Force Paper 29 May 2018 Pages: 171 - 174
Detection of Rater Errors on Cognitive Instruments in a Clinical Trial Setting Donald J. ConnorC. W. JenkinsP. Perera Original Research 22 May 2018 Pages: 188 - 196
Increased Functional Connectivity After Listening to Favored Music in Adults With Alzheimer Dementia J. B. KingK. G. JonesN. L. Foster Original Research 07 May 2018 Pages: 56 - 62
Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force Mary SanoM. SotoEU/US/CTAD Task Force members CTAD Task Force Paper 27 March 2018 Pages: 98 - 102
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer’s Disease A. H. BursteinM. SabbaghLarry Altstiel Review 22 March 2018 Pages: 149 - 154
Prevention of Alzheimer’s Disease in Chinese Populations: Status, Challenges and Directions Lei FengJ. LiChunbo Li Editorial 21 March 2018 Pages: 90 - 94
A Literature Review of Methodologies Used in Randomized Clinical Trials of Agitation in Alzheimer’s Disease Sanjay DubéJ. T. MegerianR. Malamut Brief Report 16 March 2018 Pages: 120 - 133
Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease J. LuoH. WengChengjie Xiong Brief Report 16 March 2018 Pages: 110 - 119
Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer’s Disease Task Force Jeffrey CummingsN. FoxEU/US Alzheimer’ Disease Task Force Brief Report 16 March 2018 Pages: 103 - 109
Adherence to the Mediterranean Diet Is not Related to Beta-Amyloid Deposition: Data from the Women’s Healthy Ageing Project E. HillCassandra SzoekeP. Clifton Original Research 27 February 2018 Pages: 137 - 141
Nanorobots the Future of Neurology: A Perspective on Alzheimer’s Disease Claudie HooperS. Layé Letter to Editor 20 February 2018 Pages: 155 - 156
The Integrated Alzheimer’s Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial Alette M. WesselsS. W. AndersenE. R. Siemers Original Research 20 February 2018 Pages: 134 - 136
Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial Catherine MoranA. Scotto di PalumboB. Egan Brief Report 20 February 2018 Pages: 175 - 183
Fatty acids and Alzheimer’s Disease: Evidence on Cognition and Cortical β-amyloid from Secondary Analyses of the Multidomain Alzheimer Preventive Trial Claudie HooperB. VellasMAPT/DSA study group Commentary 20 February 2018 Pages: 168 - 170
Diabetes Mellitus and Cognitive Decline – Prevention Should Not Be Delayed! Alan J. SinclairB. Vellas Editorial 20 February 2018 Pages: 95 - 97
Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial L. K. JoachimL. FrölichOliver Peters Original Research Open access 13 February 2018 Pages: 202 - 206
Detecting Treatment Group Differences in Alzheimer’s Disease Clinical Trials: A Comparison of Alzheimer’s Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB) Alette M. WesselsS. A. DowsettJ. R. Sims Original Research 11 January 2018 Pages: 15 - 20
Delayed-Start Analyses in the Phase 3 Solanezumab EXPEDITION3 Study in Mild Alzheimer’s Disease Hong Liu-SeifertM. G. CaseE. Siemers Original Research 11 January 2018 Pages: 8 - 14
Long-Term Tea Consumption and Depressive and Anxiety Symptoms in Elderly Beuy JoobV. Wiwanitkit Letter to the Editor 10 January 2018 Pages: 87 - 87
Auraptene in the Peels of Citrus Kawachiensis (Kawachibankan) Contributes to the Preservation of Cognitive Function: A Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers Michiya IgaseY. OkadaY. Ohyagi Original Research 19 December 2017 Pages: 197 - 201
Strong Relationship between Malnutrition and Cognitive Frailty in the Singapore Longitudinal Ageing Studies (SLAS-1 and SLAS-2) L. ChyeK. WeiTze-Pin Ng Original Research 05 December 2017 Pages: 142 - 148
Neuroprotective Effects of Guarana (Paullinia cupana Mart.) against Vincristine in Vitro Exposure C. F. VelosoA. K. MachadoA. F. Silveira Original Research 28 November 2017 Pages: 65 - 70
The Value of Pre-Screening in the Alzheimer’s Prevention Initiative (API) Autosomal Dominant Alzheimer’s Disease Trial Silvia Rios-RomenetsM. Giraldo-ChicaF. Lopera Original Research 07 November 2017 Pages: 49 - 54
Dementia: Creating a Knowledge-Based Healthcare Profession Charles Scerri Letter to the Editor 31 October 2017 Pages: 85 - 86
Combining Geospatial Analysis with Dementia Risk Utilising General Practice Data: A Systematic Review Nasser BagheriK. WangdiK. J. Anstey Systematic Review 21 September 2017 Pages: 71 - 77
Costs and Resource Use Associated with Alzheimer’s Disease in Italy: Results from an Observational Study G. BrunoMichele ManciniC. Reed Original Research 05 September 2017 Pages: 55 - 64
Cognitive Frailty and Incidence of Dementia in Older Persons Hiroyuki ShimadaH. MakizakoT. Suzuki Original Research 18 July 2017 Pages: 42 - 48
Care Management to Promote Treatment Adherence in Patients with Cognitive Impairment and Vascular Risk Factors: A Demonstration Project Laura M. BonnerA. HansonS. Craft Original Research 11 July 2017 Pages: 36 - 41
Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research Kaarin J. AnsteyR. Peters Editorial 11 July 2017 Pages: 2 - 4
